on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation..

despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..

the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted...